Melt-extruded orally administrable opioid formulations
US6743442B2 · kind B2 · utility
127Cited by
125References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 6, 2001 |
| Grant date | Jun 1, 2004 |
| Priority date | — |
| Expiry date | Feb 6, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/145
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Bioavailable sustained release oral opioid analgesic dosage forms, comprising a plurality of multiparticulates produced via melt extrusion techniques are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.